Selecting the optimum dose for a new soft gelatin capsule formulation of saquinavir. NV15107 Study Group (Q77398251)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 October 1998
edit
Language Label Description Also known as
English
Selecting the optimum dose for a new soft gelatin capsule formulation of saquinavir. NV15107 Study Group
scientific article published on 01 October 1998

    Statements

    Selecting the optimum dose for a new soft gelatin capsule formulation of saquinavir. NV15107 Study Group (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit